Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 336–348Open access
Impact of a Structured Intervention on Health-Related Quality of Life in Women with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Using the MDQoL-17
- 1,
- 1*
- 1 Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, KLE Academy for Higher Education and Research (KAHER), Belagavi, Karnataka, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Madiwalayya Shivakantayya Ganachari
Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, KLE Academy for Higher Education and Research (KAHER), Belagavi, Karnataka, INDIA.
Email: msganachari@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- May 6, 2025
- Accepted:
- Sep 17, 2025
- DOI:
- 10.5530/ijpi.20260495
How to cite
Deshpande, A. S., & Ganachari, M. S. (2026). Impact of a Structured Intervention on Health-Related Quality of Life in Women with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Using the MDQoL-17. International Journal of Pharmaceutical Investigation, 16(1), 336–348. https://doi.org/10.5530/ijpi.20260495
Abstract
Background
Diabetes Mellitus (DM) is a long-term health condition that can greatly impact Health-Related Quality of Life (HRQOL), especially in women, who often encounter specific difficulties in managing the disease.
Objectives
The current study aimed to evaluate the influence of the Modified Diabetes Quality of Life-17 (MDQoL-17) questionnaire on women diagnosed with Type 2 Diabetes Mellitus (T2DM).
Materials and Methods
This prospective randomized controlled trial was conducted at a tertiary care teaching hospital in Belagavi, Karnataka. A total of 218 women diagnosed with T2DM were randomized into intervention and control groups (109 each). Participants were assessed using the MDQoL-17 questionnaire, which evaluates seven domains of HRQoL. Statistical analysis included independent-sample t-test and one-way ANOVA, with a p-value <0.05 considered significant.
Results
At the baseline of the study, both groups showed similar HRQoL scores across all domains. After 9 months, the intervention group showed statistically significant improvements in mean scores in several areas, such as physical functioning (p=0.011), emotional well-being (p=0.023), role limitations (p=0.018), energy/fatigue (p=0.005), and general health perception (p=0.031), compared to the control group. Enhanced HRQoL was positively linked with better glycemic control, improved medication adherence, and the absence of diabetes-related complications.
Conclusion
The study demonstrates that targeted interventions can significantly enhance HRQoL in women with T2DM. By addressing key domains such as physical functioning, emotional well-being, and general health perception, healthcare providers can support a more holistic approach to diabetes management. Utilizing tools like the MDQoL-17 enables the identification of specific areas where patients experience the most impact, facilitating tailored strategies to improve overall well-being and day-to-day functioning.
Keywords
Subject
Article metadata
| Title | Impact of a Structured Intervention on Health-Related Quality of Life in Women with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Using the MDQoL-17 |
|---|---|
| Authors | Anushree Shrikant Deshpande; Madiwalayya Shivakantayya Ganachari |
| Affiliations | Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, KLE Academy for Higher Education and Research (KAHER), Belagavi, Karnataka, INDIA. |
| Corresponding author | msganachari@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50